Abstract: The present invention relates to pharmaceutical compositions of cannabidiol comprising less than 0.3% of THC for treating various anxiety disorders. The invention also discloses evaluation of efficacy, safety and pharmacokinetics of these compositions for treating mild to moderate anxiety disorders.
DESC:Enclosed ,CLAIMS:Enclosed
| # | Name | Date |
|---|---|---|
| 1 | 202441028160-STATEMENT OF UNDERTAKING (FORM 3) [05-04-2024(online)].pdf | 2024-04-05 |
| 2 | 202441028160-PROVISIONAL SPECIFICATION [05-04-2024(online)].pdf | 2024-04-05 |
| 3 | 202441028160-FORM FOR SMALL ENTITY(FORM-28) [05-04-2024(online)].pdf | 2024-04-05 |
| 4 | 202441028160-FORM FOR SMALL ENTITY [05-04-2024(online)].pdf | 2024-04-05 |
| 5 | 202441028160-FORM 1 [05-04-2024(online)].pdf | 2024-04-05 |
| 6 | 202441028160-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [05-04-2024(online)].pdf | 2024-04-05 |
| 7 | 202441028160-EVIDENCE FOR REGISTRATION UNDER SSI [05-04-2024(online)].pdf | 2024-04-05 |
| 8 | 202441028160-DRAWINGS [05-04-2024(online)].pdf | 2024-04-05 |
| 9 | 202441028160-FORM-5 [05-04-2025(online)].pdf | 2025-04-05 |
| 10 | 202441028160-FORM FOR SMALL ENTITY [05-04-2025(online)].pdf | 2025-04-05 |
| 11 | 202441028160-EVIDENCE FOR REGISTRATION UNDER SSI [05-04-2025(online)].pdf | 2025-04-05 |
| 12 | 202441028160-DRAWING [05-04-2025(online)].pdf | 2025-04-05 |
| 13 | 202441028160-COMPLETE SPECIFICATION [05-04-2025(online)].pdf | 2025-04-05 |
| 14 | 202441028160-Request Letter-Correspondence [05-05-2025(online)].pdf | 2025-05-05 |
| 15 | 202441028160-FORM28 [05-05-2025(online)].pdf | 2025-05-05 |
| 16 | 202441028160-Form 1 (Submitted on date of filing) [05-05-2025(online)].pdf | 2025-05-05 |
| 17 | 202441028160-Covering Letter [05-05-2025(online)].pdf | 2025-05-05 |